InvestSMART

Cogstate Limited (ASX: CGS) - Announcements

Current share price for CGS : $3.000 0.09 (2.91%)+

ASX company news and announcements for Cogstate Limited (CGS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cogstate Limited (CGS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cogstate Limited (CGS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cogstate Limited (CGS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$515 Full Year Financial Results Summary 13 Aug 2018 8:29AM $0.510 $3.000 risen by 488.24%
$515 Appendix 4E and Preliminary Final Report 13 Aug 2018 8:28AM $0.510 $3.000 risen by 488.24%
$515 Appendix 3B 9 Aug 2018 3:00PM $0.525 $3.000 risen by 471.43%
$515 Notification of Full Year Results & Investor Conference Call 9 Aug 2018 12:21PM $0.525 $3.000 risen by 471.43%
$515 Business Update 31 Jul 2018 2:16PM $0.510 $3.000 risen by 488.24%
$515 Business Update and Appendix 4C 20 Jul 2018 11:25AM $0.785 $3.000 risen by 282.17%
$515 AD trial discontinued - limited CGS impact 13 Jun 2018 8:21AM $0.710 $3.000 risen by 322.54%
$515 Cogstate announces European approval for Cognigram 5 Jun 2018 9:05AM $0.740 $3.000 risen by 305.41%
$515 Appendix 3B 1 May 2018 9:42AM $0.835 $3.000 risen by 259.28%
$515 Change to senior management team 1 May 2018 9:40AM $0.835 $3.000 risen by 259.28%
$515 Business Update & Appendix 4C 12 Apr 2018 9:53AM $0.840 $3.000 risen by 257.14%
$515 Appendix 3B 9 Apr 2018 12:07PM $0.830 $3.000 risen by 261.45%
$515 Cogstate Establishes Rare Disease and Pediatric Expertise 6 Apr 2018 9:22AM $0.810 $3.000 risen by 270.37%
$515 Appendix 3B 14 Mar 2018 2:20PM $0.850 $3.000 risen by 252.94%
$515 S&P DJ Indices Announces March Quarterly Rebalance 9 Mar 2018 8:28AM $0.835 $3.000 risen by 259.28%
$515 Investor Presentation 21 Feb 2018 9:49AM $0.935 $3.000 risen by 220.86%
$515 Appendix 4D & Half Year Financial Report 21 Feb 2018 8:26AM $0.935 $3.000 risen by 220.86%
$515 Notification of Half Year Results & Investor Conference Call 14 Feb 2018 10:17AM $0.885 $3.000 risen by 238.98%
$515 Investor Presentation 29 Jan 2018 9:06AM $0.870 $3.000 risen by 244.83%
$515 Change of Director's Interest Notice 29 Jan 2018 9:04AM $0.870 $3.000 risen by 244.83%
$515 Global Alzheimer Platform Foundation Selects Cogstate 25 Jan 2018 8:50AM $0.870 $3.000 risen by 244.83%
$515 Business Update & Appendix 4C 22 Jan 2018 9:21AM $0.945 $3.000 risen by 217.46%
$515 Appendix 3B 3 Jan 2018 11:01AM $0.895 $3.000 risen by 235.20%
$515 Change of Director's Interest Notice 7 Dec 2017 9:52AM $0.940 $3.000 risen by 219.15%
$515 Interim Business Update 5 Dec 2017 2:15PM $0.905 $3.000 risen by 231.49%

651 - 675 of 1000 results

Page 27 of 40

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.